Comment on

• Uropathogenic Escherichia coli infection-induced epithelial trained immunity impacts urinary tract disease outcome.

  Russell SK, Harrison JK, Olson BS, Lee HJ, O'Brien VP, Xing X, Livny J, Yu L, Roberson EDO, Bomjan R, Fan C, Sha M, Estfanous S, Amer AO, Colonna M, Stappenbeck TS, Wang T, Hannan TJ, Hultgren SJ. Russell SK, et al. Nat Microbiol. 2023 May;8(5):875-888. doi: 10.1038/s41564-023-01346-6. Epub 2023 Apr 10. Nat Microbiol. 2023. PMID: 37037942 Free PMC article.
• Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling.

  Zhang W, Lee AM, Jena S, Huang Y, Ho Y, Tietz KT, Miller CR, Su MC, Mentzer J, Ling AL, Li Y, Dehm SM, Huang RS. Zhang W, et al. Proc Natl Acad Sci U S A. 2023 Apr 25;120(17):e2218522120. doi: 10.1073/pnas.2218522120. Epub 2023 Apr 17. Proc Natl Acad Sci U S A. 2023. PMID: 37068243 Free PMC article.
• Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.

  Robertson AG, Meghani K, Cooley LF, McLaughlin KA, Fall LA, Yu Y, Castro MAA, Groeneveld CS, de Reyniès A, Nazarov VI, Tsvetkov VO, Choy B, Raggi D, Marandino L, Montorsi F, Powles T, Necchi A, Meeks JJ. Robertson AG, et al. Nat Commun. 2023 Apr 27;14(1):2126. doi: 10.1038/s41467-023-37568-9. Nat Commun. 2023. PMID: 37105962 Free PMC article.